Quick answer
What is Gonadorelin?
Built from index records dated 2026-10-09 to 2026-10-13 Compiled by an automated pipeline, checked by The Peptide Observer editorial desk How this site works
Gonadorelin is a peptide, grouped on this site under Endocrine and immune signalling peptides, and the 12 research records kept here are 1 from a study in rats or mice and 11 that do not state what kind of study it is.
The literature search returned 333 records. This site keeps 12 of them, which is 3.6 per cent of what came back.
What it is
This site puts it in the Endocrine and immune signalling peptides group.
The releasing hormone of the reproductive axis; the retrieved records report luteinising hormone and follicle-stimulating hormone responses to its administration.[1, 2]
Stated in the titles of the cited 1990 and 2015 Theriogenology papers.
What kind of records
The records kept here are animal and laboratory studies only.
That sentence is produced by counting, not by reading. What was counted: no interventional human trial record; 1 rodent and 0 in vitro records among 12.
What this does not settle
- What it does in a body. Counting records is not reading them, and nothing here has been read in full.
- Whether it causes harm. No adverse-effect row was taken from any source for this entry.
- How long it lasts. No pharmacokinetics source was retrieved for this entry.
- What the other 321 retrieved records say. They are not in this index.
The longer explanation
Where this comes from
The records cited above, in full.
- LH and FSH response of Holstein heifers to fertirelin acetate, gonadorelin and buserelin. Theriogenology (1990). pmid:16726818
- Effect of gonadorelin, lecirelin, and buserelin on LH surge, ovulation, and progesterone in cattle. Theriogenology (2015). pmid:25890780